MBX Biosciences(MBX)
CARMEL, INBiotechnology
Focus: MBX Biosciences is a publicly traded biotech company focused on hormone analogues for rare endocrine diseases, headquartered in Carmel, Indiana. The company operates in a specialized niche within endocrinology and rare diseases with a pre-revenue or early-stage commercial model.
Profile data last refreshed 10h ago · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Total Funding
$130M
Open Jobs
9
Should You Work at MBX Biosciences?
AI assessmentMBX is a high-risk, high-potential-reward play best suited for biotech professionals comfortable with pre-revenue stage science, rare disease focus, and meaningful equity upside contingent on Phase 2→3 advancement.
Why Work Here
- Rare disease focus provides deep clinical expertise and meaningful patient impact in underserved endocrine indications.
Data completeness
5/9 — Partial
Company HealthSolid
Pipeline
Early-stage
7 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
MBX 2109
HealthyClinical Trials (1)
NCT05158335Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of MBX 2109 in Healthy Adult Subjects
Phase 1Help build intelligence for MBX Biosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.